Olin (NYSE:OLN) Coverage Initiated by Analysts at KeyCorp

Key Points

• KeyCorp initiated coverage of Olin with an “overweight” rating and a $26 price target, implying 50.5% upside from the stock’s previous close. The firm projected EPS of $0.06 for Q3 2026, a loss of $0.20 for Q4 2026, and $1.35 for FY2028.
• Analyst sentiment remains cautious overall: Olin has a consensus “Reduce” rating and an average price target of $22.62, with 10 Hold and four Sell ratings among covering analysts.
• Olin shares opened at $17.27 after falling 1.1%; the company recently reported a quarterly loss of $0.12 per share, missing estimates by $0.25, while revenue declined 0.9% year over year to $1.74 billion.

KeyCorp initiated coverage on shares of Olin (NYSE:OLN - Get Free Report) in a report issued on Friday, Marketbeat Ratings reports. The firm set an "overweight" rating and a $26.00 price target on the specialty chemicals company's stock. KeyCorp's price target would indicate a potential upside of 50.51% from the stock's previous close. KeyCorp also issued estimates for Olin's Q3 2026 earnings at $0.06 EPS, Q4 2026 earnings at ($0.20) EPS and FY2028 earnings at $1.35 EPS.

Several other research analysts also recently weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Olin from $26.00 to $25.00 and set a "neutral" rating for the company in a research report on Thursday, June 18th. UBS Group reduced their price objective on Olin from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Mizuho lifted their target price on shares of Olin from $23.00 to $24.00 and gave the stock a "neutral" rating in a research note on Friday, July 31st. Wells Fargo & Company reiterated an "equal weight" rating and issued a $20.00 price objective (down from $25.00) on shares of Olin in a report on Monday, August 3rd. Finally, BMO Capital Markets lowered their price objective on Olin from $30.00 to $25.00 and set a "market perform" rating on the stock in a research note on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, ten have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, Olin presently has a consensus rating of "Reduce" and an average price target of $22.62.

Olin Stock Down 1.1%

OLN opened at $17.27 on Friday. The company has a fifty day moving average of $19.57 and a two-hundred day moving average of $23.56. The stock has a market capitalization of $1.97 billion, a price-to-earnings ratio of -14.04 and a beta of 1.20. Olin has a fifty-two week low of $16.73 and a fifty-two week high of $30.46. The company has a debt-to-equity ratio of 1.77, a quick ratio of 0.87 and a current ratio of 1.42.

Olin (NYSE:OLN - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The specialty chemicals company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.25). The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.81 billion. Olin had a negative net margin of 2.08% and a negative return on equity of 4.76%. Olin's revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.01) EPS. On average, research analysts expect that Olin will post -0.68 earnings per share for the current year.

Institutional Investors Weigh In On Olin

Large investors have recently bought and sold shares of the stock. Hotchkis & Wiley Capital Management LLC raised its position in shares of Olin by 5.5% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 12,690,488 shares of the specialty chemicals company's stock worth $317,135,000 after acquiring an additional 661,730 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Olin by 22.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,627,997 shares of the specialty chemicals company's stock worth $167,311,000 after acquiring an additional 1,031,498 shares in the last quarter. State Street Corp lifted its position in Olin by 1.1% in the second quarter. State Street Corp now owns 4,830,406 shares of the specialty chemicals company's stock valued at $97,043,000 after acquiring an additional 50,309 shares during the last quarter. Pzena Investment Management LLC boosted its stake in Olin by 17.5% in the fourth quarter. Pzena Investment Management LLC now owns 4,507,913 shares of the specialty chemicals company's stock valued at $93,900,000 after acquiring an additional 671,250 shares in the last quarter. Finally, Orbis Allan Gray Ltd boosted its stake in Olin by 448.9% in the fourth quarter. Orbis Allan Gray Ltd now owns 3,804,561 shares of the specialty chemicals company's stock valued at $79,249,000 after acquiring an additional 3,111,393 shares in the last quarter. Hedge funds and other institutional investors own 88.67% of the company's stock.

About Olin

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company's core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin's chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.